Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.
Noto A, De Vitis C, Pisanu ME, Roscilli G, Ricci G, Catizone A, Sorrentino G, Chianese G, Taglialatela-Scafati O, Trisciuoglio D, Del Bufalo D, Di Martile M, Di Napoli A, Ruco L, Costantini S, Jakopin Z, Budillon A, Melino G, Del Sal G, Ciliberto G, Mancini R. Noto A, et al. Among authors: pisanu me. Oncogene. 2017 Aug 10;36(32):4573-4584. doi: 10.1038/onc.2017.75. Epub 2017 Apr 3. Oncogene. 2017. PMID: 28368399
A multi-marker integrative analysis reveals benefits and risks of bariatric surgery.
Palleschi S, Guglielmi V, Nisticò L, Ferreri C, Tabolacci C, Facchiano F, Iorio E, Giuliani A, Brescianini S, Medda E, Fagnani C, Rossi B, Minoprio A, Chirico M, Pisanu ME, Di Nolfo F, Fortini P, Simonelli V, Baccarini S, Laterza S, Morretti T, Dell'Orso A, Manganello F, Gentileschi P, Sbraccia P, Dogliotti E. Palleschi S, et al. Among authors: pisanu me. Sci Rep. 2022 Nov 7;12(1):18877. doi: 10.1038/s41598-022-23241-6. Sci Rep. 2022. PMID: 36344536 Free PMC article.
Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma.
Pisanu ME, Maugeri-Saccà M, Fattore L, Bruschini S, De Vitis C, Tabbì E, Bellei B, Migliano E, Kovacs D, Camera E, Picardo M, Jakopin Z, Cippitelli C, Bartolazzi A, Raffa S, Torrisi MR, Fulciniti F, Ascierto PA, Ciliberto G, Mancini R. Pisanu ME, et al. J Exp Clin Cancer Res. 2018 Dec 17;37(1):318. doi: 10.1186/s13046-018-0989-7. J Exp Clin Cancer Res. 2018. PMID: 30558661 Free PMC article.
Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies.
Fattore L, Marra E, Pisanu ME, Noto A, de Vitis C, Belleudi F, Aurisicchio L, Mancini R, Torrisi MR, Ascierto PA, Ciliberto G. Fattore L, et al. Among authors: pisanu me. J Transl Med. 2013 Jul 27;11:180. doi: 10.1186/1479-5876-11-180. J Transl Med. 2013. PMID: 23890105 Free PMC article.
Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma.
Fattore L, Malpicci D, Marra E, Belleudi F, Noto A, De Vitis C, Pisanu ME, Coluccia P, Camerlingo R, Roscilli G, Ribas A, Di Napoli A, Torrisi MR, Aurisicchio L, Ascierto PA, Mancini R, Ciliberto G. Fattore L, et al. Among authors: pisanu me. Oncotarget. 2015 Sep 22;6(28):24823-41. doi: 10.18632/oncotarget.4485. Oncotarget. 2015. PMID: 26208478 Free PMC article.
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma.
Fattore L, Ruggiero CF, Pisanu ME, Liguoro D, Cerri A, Costantini S, Capone F, Acunzo M, Romano G, Nigita G, Mallardo D, Ragone C, Carriero MV, Budillon A, Botti G, Ascierto PA, Mancini R, Ciliberto G. Fattore L, et al. Among authors: pisanu me. Cell Death Differ. 2019 Jul;26(7):1267-1282. doi: 10.1038/s41418-018-0205-5. Epub 2018 Sep 25. Cell Death Differ. 2019. PMID: 30254376 Free PMC article.
Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted Therapy.
Podo F, Paris L, Cecchetti S, Spadaro F, Abalsamo L, Ramoni C, Ricci A, Pisanu ME, Sardanelli F, Canese R, Iorio E. Podo F, et al. Among authors: pisanu me. Front Oncol. 2016 Aug 2;6:171. doi: 10.3389/fonc.2016.00171. eCollection 2016. Front Oncol. 2016. PMID: 27532027 Free PMC article.
AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism.
Vitaliti A, Roccatani I, Iorio E, Perta N, Gismondi A, Chirico M, Pisanu ME, Di Marino D, Canini A, De Luca A, Rossi L. Vitaliti A, et al. Among authors: pisanu me. Cell Oncol (Dordr). 2023 Feb;46(1):93-115. doi: 10.1007/s13402-022-00738-w. Epub 2022 Dec 1. Cell Oncol (Dordr). 2023. PMID: 36454513 Free PMC article.
33 results